PCSK 9 Inhibition as Secondary Prevention in Renal Transplant Patients With Cardiovascular Disease.
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Evolocumab (Primary)
- Indications Atherosclerosis; Myocardial infarction; Peripheral arterial disorders; Stroke
- Focus Therapeutic Use
- 21 Dec 2020 New trial record